Innate Pharma SA-Spons ADRIPHA
13F holders, Q2 2026 (June 30)10holders +1
3new positions
2sold out
1famous investor
$1.84avg. 13F price*
At the end of Q2 2026, 10 institutions reported holding Innate Pharma SA-Spons ADR (IPHA) in their 13F filings, up 1 from Q1 2026. 3 opened new positions and 2 sold out. The largest holders were Lion Point Capital, LP ($149K), Morgan Stanley ($80K) and SmartHarvest Portfolios, LLC ($44K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Innate Pharma SA-Spons ADR
- CUSIP
- 45781K204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $94K |
| Exits | 2 | $13K |
All 13F filers, Q1 2026 → Q2 2026: 51,834 shares bought and 43,367 shares sold, net +8,467 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Lion Point Capital, LP | 0.71% | No change | 81,151 | $149K |
| Morgan Stanley | 0.00% | No change | 43,524 | $80K |
| SmartHarvest Portfolios, LLC | 0.01% | New | 23,750 | $44K |
| XTX Topco Ltd | 0.00% | New | 15,130 | $28K |
| Citadel Advisors | 0.00% | New | 12,441 | $23K |
| Jane Street Group, LLC | 0.00% | Reduce -76.2% | 10,310 | $19K |
| Rhumbline Advisers | 0.00% | Reduce -0.3% | 4,719 | $9K |
| UBS Group AG | 0.00% | Add +58.3% | 1,363 | $3K |
| Farther Finance Advisors, LLC | 0.00% | Add +110.0% | 21 | $38 |
| GAMMA Investing LLC | 0.00% | Reduce -96.3% | 9 | $17 |
"% of holder's portfolio" is IPHA's weight in each manager's 13F, not the share of Innate Pharma SA-Spons ADR the manager owns.